KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 63 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,621,645 | +245.6% | 208,500 | +180.1% | 0.03% | +211.1% |
| Q2 2023 | $1,047,974 | +49.8% | 74,430 | +14.5% | 0.01% | +28.6% |
| Q1 2023 | $699,378 | -6.6% | 64,998 | +30.0% | 0.01% | +16.7% |
| Q4 2022 | $749,000 | -7.5% | 50,000 | +57.2% | 0.01% | -45.5% |
| Q2 2020 | $810,000 | +88.4% | 31,800 | -18.3% | 0.01% | +10.0% |
| Q4 2019 | $430,000 | – | 38,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $8,988,000 | 1.31% |
| Rubric Capital Management LP | 1,569,503 | $23,511,155 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 307,283 | $4,603,099 | 0.99% |
| HHLR ADVISORS, LTD. | 2,623,924 | $39,306,382 | 0.83% |
| Parkman Healthcare Partners LLC | 191,307 | $2,865,779 | 0.76% |
| AlphaCentric Advisors LLC | 45,000 | $674,100 | 0.67% |
| RICE HALL JAMES & ASSOCIATES, LLC | 697,162 | $10,443,487 | 0.60% |
| Lion Point Capital, LP | 346,500 | $3,689,000 | 0.52% |
| EAM Global Investors LLC | 116,864 | $1,750,623 | 0.45% |
| Jackson Creek Investment Advisors LLC | 61,609 | $923 | 0.41% |